Cerro L, Valencia J, Calle P, León A, Jaimes F
Grupo Académico de Epidemiología Clínica, Departamento de Medicina Interna, Universidad de Antioquia, Medellín, Colombia.
Grupo Académico de Epidemiología Clínica, Departamento de Medicina Interna, Universidad de Antioquia, Medellín, Colombia.
Rev Esp Anestesiol Reanim. 2014 Mar;61(3):125-32. doi: 10.1016/j.redar.2013.11.014. Epub 2014 Jan 25.
To validate the APACHE II and SOFA scores in patients with suspected infection in clinical settings other than intensive care units.
A secondary analysis was performed on 2,530 adult patients participating in 2 cohort studies, with suspected infection as admission diagnosis within the first 24 h of hospitalization. The performance of both scoring systems was studied in order to set calibration and discrimination, respectively, on the outcomes such as mortality, admission to Intensive Care Unit, development of septic shock, or multiple organ dysfunctions.
The AUC-ROC values for mortality at discharge and on day 28 in the first cohort were around 0.50 for the SOFA and APACHE II scores; whereas for the second cohort the discrimination value was around 0.70. Calibration of both scoring systems for primary outcomes, according to Hosmer-Lemeshow test, showed p>.05 in the first cohort; while in the second cohort calibration it only showed a p>.05 in the case of the SOFA for mortality at hospital discharge.
This validation study of SOFA and APACHE II scores in patients with suspected infection in-hospital units other than the Intensive Care Unit, showed no consistent performance for calibration and discrimination. Its application in emergency and in-hospital patients is limited.
在重症监护病房以外的临床环境中,验证急性生理与慢性健康状况评分系统(APACHE II)和序贯器官衰竭评估(SOFA)评分在疑似感染患者中的有效性。
对参与两项队列研究的2530例成年患者进行二次分析,这些患者在住院的前24小时内以疑似感染作为入院诊断。研究了这两种评分系统的性能,以便分别针对死亡率、入住重症监护病房、发生感染性休克或多器官功能障碍等结局进行校准和鉴别。
在第一个队列中,出院时和第28天死亡率的受试者工作特征曲线下面积(AUC-ROC)值,SOFA和APACHE II评分约为0.50;而在第二个队列中,鉴别值约为0.70。根据Hosmer-Lemeshow检验,两种评分系统对主要结局的校准在第一个队列中显示p>0.05;而在第二个队列校准中,仅在SOFA用于出院时死亡率的情况下显示p>0.05。
这项在重症监护病房以外的医院科室对疑似感染患者进行的SOFA和APACHE II评分验证研究,在校准和鉴别方面未显示出一致的性能。其在急诊和住院患者中的应用有限。